Latest news
Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041 - biospace.combiospace.com · Thu, 30 Jul 2026 16:29:51 GMTAlpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease - biospace.combiospace.com · Wed, 29 Jul 2026 07:00:00 GMT